Drug Discovery and Development

Drug Discovery and Development is a comprehensive master's programme offered by the University of Turku, designed to equip students with interdisciplinary knowledge and practical skills essential for the pharmaceutical and biotech industries. This programme provides a deep understanding of the entire drug development process, from initial target identification and validation to preclinical and clinical testing, as well as regulatory approval and market entry. Students will explore various fields, including medicinal chemistry, pharmacology, pharmacokinetics, drug formulation, and analysis, gaining a holistic view of how new medicines are discovered, developed, and brought to market.

The programme emphasizes a hands-on approach, combining theoretical coursework with practical laboratory work, project-based learning, and collaborations with industry partners. This allows students to apply their knowledge to real-world challenges, fostering innovation and problem-solving skills crucial for successful careers in drug research and development. Students will also develop competence in the use of modern technologies and methods, such as high-throughput screening, molecular modeling, and bioinformatics, which are vital tools in modern drug discovery.

Furthermore, the programme prepares students for diverse roles within the pharmaceutical sector, biotech startups, research institutions, and regulatory agencies. Graduates will possess a solid foundation in scientific research, project management, and regulatory processes, enabling them to navigate the complex landscape of drug development effectively. The curriculum also encourages international collaboration, critical thinking, and continuous learning, preparing students to adapt to the evolving challenges of the pharmaceutical industry.

By studying at the University of Turku, students become part of a dynamic academic community that values innovation, research excellence, and sustainability. The programme’s strong connections with industry stakeholders provide valuable networking opportunities, internships, and potential employment pathways. Graduates are well-positioned to contribute to the development of new medicines that can improve health outcomes worldwide, making a tangible impact in science, healthcare, and society.

The MSc Degree Programme in Drug Discovery and Development at the University of Turku offers students a comprehensive education in the scientific and practical aspects of discovering and developing new pharmaceutical compounds. This program is designed to provide students with a solid foundation in medicinal chemistry, pharmacology, biochemistry, and drug safety evaluation, preparing them for diverse careers within the pharmaceutical industry, research institutions, and regulatory agencies. Throughout the programme, students will explore the entire drug development pipeline, from initial target identification and lead compound discovery to preclinical testing, clinical trials, and regulatory approval processes. The curriculum combines theoretical coursework with practical laboratory training, fostering skills in compound synthesis, biological screening, data analysis, and project management. Students will also gain proficiency in modern technologies such as high-throughput screening, molecular modeling, and bioinformatics. An integral part of the degree is participating in research projects and internships, enabling students to apply their knowledge in real-world settings and build professional networks. The programme emphasizes interdisciplinary collaboration, critical thinking, and innovation, essential for addressing current challenges in drug development. Graduates will be well-equipped to pursue careers in pharmaceutical companies, biotechnology firms, clinical research organizations, or continue academic research through doctoral studies. The degree is delivered in English, ensuring that students develop language competencies necessary for international scientific work. The University of Turku’s strong connections with the industry and research communities ensure that students receive up-to-date knowledge and opportunities to engage with leading experts. Overall, the Drug Discovery and Development MSc programme offers a rigorous and versatile education for those passionate about advancing healthcare through new medicinal solutions.

The Programme is open to applicants who have sufficient background knowledge in biological and/or natural sciences and have completed a lower university degree, BSc degree (180 ECTS), in the field of:

• biomedical sciences
• pharmacology
• pharmacy
• biochemistry
• biology
• medical sciences
• other life sciences
• bioengineering
• chemistry

The applicants should be familiar with the basics of laboratory practice and pharmacology. Both Finnish and international students are welcome to apply to the Programme.

The student selection has two stages. First, the admission committee selects the candidates for an interview by scoring the following application components:

• Previous studies in the relevant fields
• Previous academic success and study history
• Laboratory working experience
• Motivation letter

The best scoring applicants will be invited for the interview. Selected applicants will be invited to the interview 1-2 weeks in advance. Interviews will be held via Skype.

The interview performance, including English skills, is separately scored.

The Drug Discovery and Development master's programme at the University of Turku offers students various opportunities for financing their studies, though specific scholarship options tailored exclusively for this program are not explicitly detailed on the university’s official website. Generally, the university provides a range of financial aid options for both Finnish and international students enrolled in master's degree programmes. These include merit-based scholarships, which are awarded to the most outstanding applicants and are intended to cover tuition fees either partially or in full. Applicants are typically automatically considered for these scholarships during the admissions process, based on their academic achievements and motivation.

In addition to university-funded scholarships, students may explore external funding sources such as government or private sector grants and scholarships available in their home countries or international funding organizations. The Finnish government and the EU also offer various scholarship programs, which students can apply for to support their studies in Finland. Apart from scholarships, students can look into student loans, although eligibility and availability depend on the student’s nationality and other factors.

Tuition fees for non-EU/EEA students are charged, and the cost varies depending on the programme, but the university encourages prospective students to plan financial support in advance. The University of Turku also provides guidance and counseling regarding funding options upon admission or during studies. Students are advised to consult the university’s official website or contact the admissions office for detailed, up-to-date information on available scholarships and financial aid programs applicable to the Drug Discovery and Development programme.

Furthermore, students engaged in research or internships may have opportunities for stipends or grants, particularly if participating in projects funded through university collaborations or external agencies. Financial planning is an integral part of the student’s journey, and seeking early advice from university financial services helps in organizing sufficient resources to focus on academic success. Overall, while specific financing details for this master's programme are not explicitly listed, the combination of university scholarships, external funding options, and personal financial planning forms the cornerstone of financing studies at the University of Turku.

Drug Discovery and Development at the University of Turku offers a comprehensive interdisciplinary education aimed at preparing students for careers in the pharmaceutical and biotech industries, as well as in academic research. The programme focuses on understanding the complex processes involved in identifying new drug candidates, designing and synthesizing potential therapeutic compounds, and bringing them through preclinical and clinical phases to market approval. Students will explore key concepts such as medicinal chemistry, pharmacology, molecular biology, pharmacokinetics, and regulatory affairs, gaining both theoretical knowledge and practical laboratory skills. The curriculum includes coursework on target identification, high-throughput screening, lead optimization, and ADMET (absorption, distribution, metabolism, excretion, and toxicity) studies, providing a solid foundation in drug development pipelines.

The programme also emphasizes the importance of interdisciplinary collaboration, requiring students to work cross-functionally with chemists, biologists, and pharmacologists. Students will have access to state-of-the-art laboratories and research facilities to conduct experiments essential for drug discovery processes. The programme includes project work, internships, or collaborations with industry partners, giving students real-world experience and networking opportunities within the pharmaceutical sector.

Graduates of the programme will be equipped with skills in scientific research, data analysis, and project management necessary for developing novel therapeutics. The programme prepares students for careers in pharmaceutical companies, biotechnology firms, academic research institutes, or regulatory agencies. Furthermore, students are encouraged to engage in scientific communication, report writing, and presentation skills vital for professional success in the global health and pharmaceutical sectors.

The interdisciplinary approach of the programme aims to foster innovative thinking and problem-solving skills, aligning with fast-moving trends in personalized medicine, digital health, and targeted therapies. The University of Turku’s network with industry stakeholders ensures that students remain updated on the latest advancements and industry needs in the field of drug discovery and development. The language of instruction is English, accommodating international students and fostering a diverse learning environment. Upon graduation, students are well-prepared to contribute to the ongoing development of new medicines, ultimately aiming at improving patient outcomes and public health.